Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 131

1.

Harnessing the immune response to treat cancer.

Steer HJ, Lake RA, Nowak AK, Robinson BW.

Oncogene. 2010 Dec 2;29(48):6301-13. doi: 10.1038/onc.2010.437. Review.

PMID:
20856204
2.

Immune responses to tumour antigens: implications for antigen specific immunotherapy of cancer.

Jäger D, Jäger E, Knuth A.

J Clin Pathol. 2001 Sep;54(9):669-74. Review.

3.

The promise of 4-1BB (CD137)-mediated immunomodulation and the immunotherapy of cancer.

Lynch DH.

Immunol Rev. 2008 Apr;222:277-86. doi: 10.1111/j.1600-065X.2008.00621.x. Review.

PMID:
18364008
4.

Roles of tumour localization, second signals and cross priming in cytotoxic T-cell induction.

Ochsenbein AF, Sierro S, Odermatt B, Pericin M, Karrer U, Hermans J, Hemmi S, Hengartner H, Zinkernagel RM.

Nature. 2001 Jun 28;411(6841):1058-64. Erratum in: Nature 2001 Sep 13;413(6852):183.

PMID:
11429607
5.

Angiostasis as a way to improve immunotherapy.

Griffioen AW, Vyth-Dreese FA.

Thromb Haemost. 2009 Jun;101(6):1025-31. Review.

PMID:
19492143
6.

[Dendritic cells and immune function in cancer].

Chaux P.

Pathol Biol (Paris). 1995 Dec;43(10):897-903. Review. French.

PMID:
8786896
7.

T-cell death and cancer immune tolerance.

Lu B, Finn OJ.

Cell Death Differ. 2008 Jan;15(1):70-9. Review.

8.

Tumour immunotherapy: the adjuvant treatment of the 21st century?

Bremers AJ, Kuppen PJ, Parmiani G.

Eur J Surg Oncol. 2000 Jun;26(4):418-24. Review.

PMID:
10873365
9.
10.

Escape strategies and reasons for failure in the interaction between tumour cells and the immune system: how can we tilt the balance towards immune-mediated cancer control?

Rivoltini L, Canese P, Huber V, Iero M, Pilla L, Valenti R, Fais S, Lozupone F, Casati C, Castelli C, Parmiani G.

Expert Opin Biol Ther. 2005 Apr;5(4):463-76. Review.

PMID:
15934826
11.

Immunotherapeutic potential of whole tumour cells.

Ward S, Casey D, Labarthe MC, Whelan M, Dalgleish A, Pandha H, Todryk S.

Cancer Immunol Immunother. 2002 Sep;51(7):351-7. Review.

PMID:
12192534
12.

Effective immunotherapy against cancer: a question of overcoming immune suppression and immune escape?

Malmberg KJ.

Cancer Immunol Immunother. 2004 Oct;53(10):879-92. Review.

PMID:
15338206
13.

Specific immunotherapy of cancer in elderly patients.

Matzku S, Zöller M.

Drugs Aging. 2001;18(9):639-64. Review.

PMID:
11599633
14.

Immune based therapies in cancer.

Krüger C, Greten TF, Korangy F.

Histol Histopathol. 2007 Jun;22(6):687-96. Review.

PMID:
17357098
15.

Immunotherapy II: Antigens, receptors and costimulation.

Searle PF, Young LS.

Cancer Metastasis Rev. 1996 Sep;15(3):329-49. Review.

PMID:
9034595
16.

Tumour escape mechanisms and their therapeutic implications in combination tumour therapy.

Bhutia SK, Mallick SK, Maiti TK.

Cell Biol Int. 2010 Apr 8;34(5):553-63. doi: 10.1042/CBI20090206. Review.

PMID:
20384587
17.

Targeting the immune system in cancer.

Chaudhuri D, Suriano R, Mittelman A, Tiwari RK.

Curr Pharm Biotechnol. 2009 Feb;10(2):166-84. Review.

PMID:
19199949
18.

Progress in human tumour immunology and immunotherapy.

Rosenberg SA.

Nature. 2001 May 17;411(6835):380-4. Review.

PMID:
11357146
19.

Mechanisms of tumor evasion from the immune response.

Rodríguez PC, Zea AH, Ochoa AC.

Cancer Chemother Biol Response Modif. 2003;21:351-64. Review.

PMID:
15338755
20.

Immune responses in cancer.

Adam JK, Odhav B, Bhoola KD.

Pharmacol Ther. 2003 Jul;99(1):113-32. Review.

PMID:
12804702
Items per page

Supplemental Content

Support Center